Chengdu
300841.SZChengdu Kanghua Biological Products Co., Ltd. Price (300841.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
133,747,266
(0.1703)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Chengdu Kanghua Biological Products Co., Ltd.Currency: CNY
| YEAR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
71,069,286.00
+0% |
92,916,354.00
+31% |
261,930,180.00
+182% |
559,467,534.00
+114% |
554,636,645.00
-1% |
1,038,636,032.00
+87% |
1,292,447,990.00
+24% |
1,446,724,761.00
+12% |
1,577,395,401.00
+9% |
||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 11,102,522.00 | 8,626,712.00 | 27,616,623.00 | 31,091,486.00 | 32,349,343.00 | 62,843,690.00 | 83,750,116.00 | 93,134,704.00 | 103,779,230.00 | ||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
59,966,764.00
+0% |
84,289,642.00
+41% |
234,313,557.00
+178% |
528,376,048.00
+125% |
522,287,302.00
-1% |
975,792,342.00
+87% |
1,208,697,874.00
+24% |
1,353,590,057.00
+12% |
1,473,616,171.00
+9% |
||||||||||
| Gross Profit Ratio | (0.84%) | (0.91%) | (0.89%) | (0.94%) | (0.94%) | (0.94%) | (0.94%) | (0.94%) | (0.93%) | ||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 5,009,185.00 | 6,355,152.00 | 4,273,989.00 | 18,922,895.00 | 22,785,779.00 | 58,253,859.00 | 78,875,462.00 | 179,941,306.00 | 253,025,564.00 | ||||||||||
| General and Administrative | 14,719,782.00 | 19,527,986.00 | 4,078,124.00 | 29,176,309.00 | 29,231,221.00 | 33,270,494.00 | 30,949,596.00 | 24,911,502.00 | 25,304,967.00 | ||||||||||
| Selling, General & Admin... | 27,214,506.00 | 49,505,063.00 | 114,880,639.00 | 278,194,921.00 | 246,268,952.00 | 404,315,080.00 | 443,019,672.00 | 453,030,865.00 | 610,867,079.00 | ||||||||||
| Selling & Marketing Exp... | 12,494,723.00 | 29,977,077.00 | 110,802,515.00 | 249,018,612.00 | 217,037,731.00 | 371,044,586.00 | 412,070,076.00 | 428,119,363.00 | 495,444,123.00 | ||||||||||
| Depreciation and Amortiz... | 10,185,600.00 | 9,965,800.00 | 9,724,800.00 | 9,339,700.00 | 10,003,682.00 | 13,978,578.00 | 21,817,986.00 | 40,950,999.00 | 51,464,347.00 | ||||||||||
| Other Expenses | 1,433,932.00 | 384,680.00 | -29,810.58 | -205,191.72 | -71,217.59 | -1,121,193.34 | 269,145,377.00 | 50,185,115.00 | 33,111,367.00 | ||||||||||
| Total Operating Expenses | 32,489,740.00 | 56,583,118.00 | 131,873,725.00 | 313,850,595.00 | 291,986,729.00 | 499,968,150.00 | 567,507,602.00 | 688,120,523.00 | 897,004,010.00 | ||||||||||
| Cost and Exponses | 43,592,263.00 | 65,209,830.00 | 159,490,349.00 | 344,942,082.00 | 324,336,073.00 | 562,811,841.00 | 651,257,719.00 | 781,255,227.00 | 1,000,783,240.00 | ||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
13,494,418.00
+0% |
6,733,974.00
-50% |
90,905,276.00
+1,250% |
189,628,978.00
+109% |
223,404,028.00
+18% |
485,059,577.00
+117% |
915,757,565.00
+89% |
685,501,884.00
-25% |
576,612,161.00
-16% |
||||||||||
| Operating Income Ratio | (0.19%) | (0.07%) | (0.35%) | (0.34%) | (0.40%) | (0.47%) | (0.71%) | (0.47%) | (0.37%) | ||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 484,034.00 | 433,672.00 | 416,344.00 | 298,345.00 | 668,481.00 | 12,459,658.00 | 21,280,275.00 | 14,255,002.00 | 12,589,388.00 | ||||||||||
| Interest Expenses | 11,559,712.00 | 10,110,281.00 | 5,123,275.00 | 441,644.00 | 532,838.00 | 230,791.00 | 72,687.00 | 3,188,702.00 | 4,805,740.00 | ||||||||||
| Total Other Income/Exp... | 1,433,932.00 | 384,681.00 | -29,811.00 | -205,192.00 | -71,217.00 | -1,121,193.00 | -178,652.00 | -1,708,929.00 | -2,618,567.00 | ||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 34,755,626.00 | 26,376,325.00 | 105,733,187.00 | 199,220,562.00 | 233,869,334.00 | 496,429,344.00 | 937,527,207.00 | 728,084,134.00 | 630,263,683.00 | ||||||||||
| EBITDA ratio | (0.56%) | (0.41%) | (0.43%) | (0.40%) | (0.43%) | (0.48%) | (0.74%) | (0.53%) | (0.40%) | ||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 14,928,350.00 | 7,118,655.00 | 90,875,465.00 | 189,423,786.00 | 223,332,811.00 | 483,938,384.00 | 915,578,913.00 | 683,792,955.00 | 573,993,594.00 | ||||||||||
| Income Before Tax Ratio | (0.21%) | (0.08%) | (0.35%) | (0.34%) | (0.40%) | (0.47%) | (0.71%) | (0.47%) | (0.36%) | ||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 3,226,662.00 | 460,725.00 | 16,417,520.00 | 35,284,108.00 | 36,646,145.00 | 75,892,116.00 | 86,101,102.00 | 85,726,739.00 | 64,777,629.00 | ||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 11,701,687.00
+0% |
6,657,929.00
-43% |
74,457,944.00
+1,018% |
154,139,677.00
+107% |
186,686,665.00
+21% |
408,046,268.00
+119% |
829,477,810.00
+103% |
598,066,216.00
-28% |
509,215,964.00
-15% |
||||||||||
| Net Income Ratio | (0.16%) | (0.07%) | (0.28%) | (0.28%) | (0.34%) | (0.39%) | (0.64%) | (0.41%) | (0.32%) | ||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.09 | 0.05 | 0.55 | 1.54 | 1.38 | 3.02 | 6.15 | 4.47 | 3.81 | ||||||||||
| Diluted EPS | 0.09 | 0.05 | 0.55 | 1.54 | 1.38 | 3.02 | 6.14 | 4.46 | 3.81 | ||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 134,999,946.00 | 134,999,946.00 | 134,999,946.00 | 100,235,339.00 | 134,999,946.00 | 134,999,946.00 | 134,971,018.00 | 133,939,401.00 | 133,747,266.00 | ||||||||||
| Diluted Share Outstanding | 134,999,946.00 | 134,999,946.00 | 134,999,946.00 | 100,235,339.00 | 134,999,946.00 | 134,999,946.00 | 134,995,913.00 | 133,975,406.00 | 133,747,266.00 | ||||||||||